As a supporting partner to medical practitioners throughout the world, Medmain develops and operates PidPort, an analytical system for pathological image diagnosis that makes use of Deep Learning, as well as Medteria, a specialized cloud-based service for medical students.
PidPort is an analytical system for pathological image diagnosis that enables super-precise, prompt pathological diagnosis using our unique Deep Learning/AI-based image processing technology. PidPort also features a remote pathological diagnosis function that leverages cloud network technology.*
AI-based pathological screening
PidPort enables highly precise and instantaneous screening of pathologic tissue and cells using AI independently developed by Medmain. As an assistant to medical practitioners, the system eases one's daily workflow.*
Globally-linked remote pathological diagnosis
PidPort's telepathology (remote pathological diagnosis) function enables optimal, timely pathological diagnosis requests and support via a network of medical practitioners around the world.
Optimal storage space for pathologic specimens
Digitization enables cloud-based management and storage of pathologic image data and case histories without the need to worry about deterioration or physical storage space.
*It is depending on the country and region, all or a certain feature are available for use. Please contact us for details.
Successful Development of an artificial intelligence (a deep learning) model to discriminate pancreatic adenocarcinoma in endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) biopsy histopathological specimens. ― Published in Scientific Reports ―
Successful Development of an Artificial Intelligence Model Using Deep Learning Approach to Establish Histological Sub-classification of Lung Cancer in Biopsy Specimens Whole Slide Images ― Published in Scientific Reports ―
Joint research by Medmain Inc. and Kyushu Medical Center will be presented at “ESMO ASIA2020 Virtual”!